BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34974204)

  • 21. [The impact of the COVID-19 epidemic on the course of the most common respiratory diseases].
    Bogos K; Berta J; Cselkó Z; Tisza J; Szilasi M; Simon B; Antus B; Vizi É; Megyesfalvi Z; Döme B; Rózsás A; Török S
    Orv Hetil; 2023 Jan; 164(2):51-56. PubMed ID: 36641759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms in patients with asthma infected by SARS-CoV-2.
    Garcia-Pachon E; Ruiz-Alcaraz S; Baeza-Martinez C; Zamora-Molina L; Soler-Sempere MJ; Padilla-Navas I; Grau-Delgado J
    Respir Med; 2021; 185():106495. PubMed ID: 34126579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 Pandemic.
    Chan KF; Kwok WC; Ma TF; Hui CH; Tam TC; Wang JK; Ho JC; Lam DC; Sau-Man Ip M; Ho PL
    Ann Am Thorac Soc; 2021 Oct; 18(10):1624-1633. PubMed ID: 33636091
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population.
    Huang BZ; Chen Z; Sidell MA; Eckel SP; Martinez MP; Lurmann F; Thomas DC; Gilliland FD; Xiang AH
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3621-3628.e2. PubMed ID: 34389242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020.
    Drouin O; Hepburn CM; Farrar DS; Baerg K; Chan K; Cyr C; Donner EJ; Embree JE; Farrell C; Forgie S; Giroux R; Kang KT; King M; Laffin M; Luu TM; Orkin J; Papenburg J; Pound CM; Price VE; Purewal R; Sadarangani M; Salvadori MI; Top KA; Viel-Thériault I; Kakkar F; Morris SK;
    CMAJ; 2021 Sep; 193(38):E1483-E1493. PubMed ID: 34580141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of COVID-19 on utilization of chronic diseases services.
    Moradi G; Piroozi B; Khayyati F; Moradpour F; Safari H; Mohamadi Bolbanabad A; Fattahi H; Younesi F; Ebrazeh A; Shokri A
    Chronic Illn; 2024 Jun; 20(2):309-319. PubMed ID: 37488977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Chiner-Vives E; Cordovilla-Pérez R; de la Rosa-Carrillo D; García-Clemente M; Izquierdo-Alonso JL; Otero-Candelera R; Pérez-de Llano L; Sellares-Torres J; de Granda-Orive JI
    Arch Bronconeumol; 2022 Apr; 58 Suppl 1():39-50. PubMed ID: 35501222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
    Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
    Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic.
    Serigstad S; Markussen DL; Ritz C; Ebbesen MH; Knoop ST; Kommedal Ø; Heggelund L; Ulvestad E; Bjørneklett RO; Grewal HMS;
    BMC Infect Dis; 2022 Sep; 22(1):763. PubMed ID: 36180842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency.
    Kappe NN; Alagem N; Tov N; Stolk J
    COPD; 2023 Dec; 20(1):292-297. PubMed ID: 37665565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity.
    Moschovis PP; Lu M; Hayden D; Yonker LM; Lombay J; Taveras E; Arauz Boudreau A; Triant VA; Foulkes AS; Bassett I; Hibberd PL; Kinane TB
    BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34740944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases.
    Guan WJ; Liang WH; Shi Y; Gan LX; Wang HB; He JX; Zhong NS
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2645-2655.e14. PubMed ID: 33684635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease.
    Cihanbeylerden M; Can Bostan O; Tuncay G; Safak C; Damadoglu E; Karakaya G; Kalyoncu AF
    Allergy Asthma Proc; 2023 Jul; 44(4):e3-e10. PubMed ID: 37480202
    [No Abstract]   [Full Text] [Related]  

  • 38. Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients.
    Yong SJ
    Med Hypotheses; 2021 Aug; 153():110628. PubMed ID: 34139599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.
    Huh K; Kim YE; Ji W; Kim DW; Lee EJ; Kim JH; Kang JM; Jung J
    Thorax; 2021 Sep; 76(9):939-941. PubMed ID: 33782081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive Effects of Pulmonary Rehabilitation Among Patients with Obstructive Ventilatory Dysfunction Post COVID-19.
    Brînduș GM; Marcu EA; Olteanu M; Trăistaru MR
    Curr Health Sci J; 2022; 48(4):426-435. PubMed ID: 37304799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.